Skip to main content
. 2022 Nov 19;14(11):2523. doi: 10.3390/pharmaceutics14112523

Figure 9.

Figure 9

(A) Retrieving the conformational biding of raloxifene with ER-α (PDB 1ERR). (B) Predicted conformational binding of N, N-Diethylamino analog of Raloxifene with ER-α. (C) Molecular structure of CRBN and VHL ligand. (D) VHL-based PROTACs (ERD-308, ERD-148).